PLK1 can activate the NF-κB signaling pathway to promote HCC development; thereby, harnessing necroptosis through inhibiting PLK1 may be a promising treatment strategy [29, 30]. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.